Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by Southwest Oncology Group
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group Identifier:
First received: October 19, 2010
Last updated: July 21, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: August 2022 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):